2015 Annual Meeting

American Association of Neuropathologists

2015 Annual Meeting

Room CC 306, March 21 2015, 7:00pm to 10:00pm

Murat Gokden, Tessa Hedley-Whyte, Sandro Santagata, Gregory Fuller, Jennifer Hunt, Tarik Tihan, Caterina Giannini

Educational Objective

Significant advances have been made in our understanding of a group of entities that can be seen in the surgical neuropathology and surgical pathology practices. Small round blue cell neoplasms commonly seen in the skull base, mesenchymal and other neoplasms with chordoid and chondroid features, as well as solitary fibrous tumor/hemangiopericytoma, and malignancies with unknown primary are commonly seen in both practice settings. Updating the knowledge base on their diagnosis, differential diagnosis and biologic behavior in the light of recent advances in their molecular biology will contribute to our mutual understanding of these biologic processes, translating into improved management of our patients. Officers of the Companion Society Meeting (CSM) within the AANP identify the topics. The officers are the Chair of the Professional Affairs Committee (PAC) and the USCAP liaison of the PAC, appointed by the PAC. The proposed program is presented to the PAC and subsequently to the President for approval. This topic was chosen to address the difficult and challenging issues that can be encountered by both the practicing surgical neuropathologists and surgical pathologists alike, in which substantial advances have been made in recent years, as well as to promote interactions and sharing of knowledge between the surgical neuropathologists and surgical pathologists. The target audience include: Surgical pathologists, pathology and neuropathology trainees, and neuropathologists who, by nature of their practice and training, are involved in the diagnosis and management of lesions which are in the border zone of surgical neuropathology and surgical pathology. Upon the completion of this activity, participants will:

  • Effectively incorporate ancillary techniques in the identification of the primary site of metastatic malignancies of unknown origin.
  • Accurately identify the differential diagnostic possibilities associated with the small round blue cell tumors of the skull base
  • Efficiently use the molecular markers in the work-up of small round blue cell tumors commonly seen in the skull base.
  • Identify the problematic mesenchymal neoplasms of the central nervous system and skull base through a systematic approach and with the use of ancillary studies.

Session Credits: CME = 3 / SAMs = N/A

Agenda

7:00pm
Companion Meeting Moderator
Speaker: Murat Gokden, MD, University of Arkansas, Little Rock, AR
7:00pm
Companion Meeting Moderator
Speaker: E. Tessa Hedley-Whyte, MD, Massachusetts General Hospital, Boston, MA
7:00pm
Opening Remarks
7:10pm
Cancer of Unknown Primary (CUP): Overview and Morphological - Immunophenotypic and Molecular Profiling Approach
Speaker: Sandro Santagata, MD, PhD, Dana-Farber Cancer Institute, Boston, MA
Handouts: View PDF
7:45pm
Questions and Answers
7:55pm
Central Nervous System Lymphoma: Diagnostic Challenges
Speaker: Caterina Giannini, MD, PhD, Mayo Clinic, Rochester, MN
Handouts: View PDF
8:20pm
Questions and Answers
8:30pm
Small Round Blue Cell Tumors of the Skull Base
Speaker: Jennifer L. Hunt, MD, University of Arkansas, Little Rock, AR
Handouts: View PDF
9:00pm
Questions and Answers
9:10pm
Mesenchymal Tumors of the CNS: New Diagnostic Tools (Part 1)-- Solitary Fibrous Tumor: Hemangiopericytoma Dichotomy Revisited
Speaker: Tarik Tihan, MD, PhD, University of California San Francisco, San Francisco, CA
Handouts: View PDF
9:30pm
Mesenchymal Tumors of the CNS: New Diagnostic Tools (Part 2)-- Update on Selected Cranial Bone Lesions
Speaker: Gregory N. Fuller, MD, PhD, MD Anderson Cancer Center, Houston, TX
Handouts: View PDF
9:50pm
Questions and Answers

Meetings

home-circle-inset-1
view more